ArticleVaccines2022

Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis.

Louise Goksøyr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.